Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06066502 · ClinicalTrials.gov registry record · Phase 3
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
A Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,100
- Enrollment target
- 20
- Study locations
NCT06066502 is a Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 1,100 participants, below the 4,496-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT06066502, a Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,100 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.
Conditions Studied
Interventions
- OTHER Precision ventilation
- OTHER Guided usual care ventilation
Study Locations (20)
California
- University of California, San Diego - La Jolla
- University of California, Los Angeles Medical Center - Los Angeles
- Cedar-Sinai Medical Center - Los Angeles
- University of California, San Francisco - San Franciso
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
New York
- NYU Lagone Health - New York
- New York City Health + Hospitals/ Bellevue - New York
- Albert Einstein College of Medicine/Montefiore Medical Center - The Bronx
Ohio
- University of Cincinnati - Cincinnati
- Cleveland Clinic Foundation - Cleveland
- Ohio State University Wexner Medical Center - Columbus
North Carolina
- Duke University Medical Center - Durham
- Atrium Health Wake Forest Baptist - Winston-Salem
Arizona
- University of Arizona - Tucson
Illinois
- University of Chicago - Chicago
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2030-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06066502
The ClinicalTrials.gov registry entry for NCT06066502 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,496-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Precision ventilation is the first listed.
NCT06066502 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT06066502 about?
NCT06066502 is a clinical study titled "Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome". The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study ho...
What is the current status of trial NCT06066502?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,100 participants. The study started on 2024-06-24. Estimated completion is 2030-08-31.
What conditions does trial NCT06066502 study?
This clinical trial studies the following conditions: Respiratory Failure, Acute Respiratory Distress Syndrome.
What interventions are being tested in trial NCT06066502?
The interventions under investigation include: Precision ventilation (OTHER), Guided usual care ventilation (OTHER).
Who is sponsoring clinical trial NCT06066502?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06066502 being conducted?
This trial has 20 study locations across Arizona, California, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cuff Leak Test and Airway Obstruction in Mechanically Ventilated ICU Patients
COMPLETED · Phase 3
-
Heart And Lung Failure - Pediatric INsulin Titration Trial
COMPLETED · Phase 3
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.